GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trellus Health PLC (LSE:TRLS) » Definitions » Forward PE Ratio

Trellus Health (LSE:TRLS) Forward PE Ratio : 0.00 (As of May. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Trellus Health Forward PE Ratio?

Trellus Health's Forward PE Ratio for today is 0.00.

Trellus Health's PE Ratio without NRI for today is 0.00.

Trellus Health's PE Ratio (TTM) for today is 0.00.


Trellus Health Forward PE Ratio Historical Data

The historical data trend for Trellus Health's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trellus Health Forward PE Ratio Chart

Trellus Health Annual Data
Trend
Forward PE Ratio

Trellus Health Semi-Annual Data
Forward PE Ratio

Competitive Comparison of Trellus Health's Forward PE Ratio

For the Health Information Services subindustry, Trellus Health's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trellus Health's Forward PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Trellus Health's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Trellus Health's Forward PE Ratio falls into.


;
;

Trellus Health Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Trellus Health  (LSE:TRLS) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Trellus Health Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Trellus Health's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Trellus Health Business Description

Traded in Other Exchanges
N/A
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.

Trellus Health Headlines

No Headlines